Flexibility for Your Patients

Please select an indication:


Self-administration gives you and your patients the freedom to choose:

Infusion calendar icon

Your patient's routine

Infusion timing icon

How long infusions take

Infusion dose icon

How much medicine per infusion

Infusion sites icon

How many infusion sites

Hizentra is indicated for the treatment of primary immune deficiency (PI) in adults and pediatric patients 2 years older, and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.

Frequently asked questions about Hizentra

Want to know more about Hizentra? We have the answers to prescribers' frequently asked questions.

See the answers
Hizentra dosing and administration

Explore helpful tools for and additional information about self-infusing Hizentra.

See dosing options and administration

View information about Hizentra for:


chronic inflammatory demyelinating polyneuropathy


primary immunodeficiency

You are now leaving the current website.

Do you want to continue?

No Yes